The National Institute for Health and Care Excellence

Major changes to type 2 diabetes treatment could save thousands of lives

People diagnosed with type 2 diabetes before age 40 face a higher lifetime risk of heart and kidney problems, so may benefit from adding another type of medicine called a GLP-1 receptor agonist (such ...
Medscape

NICE Updates First-Line Type 2 Diabetes Care

NICE recommends SGLT-2 inhibitors with metformin at diagnosis, citing major cardiovascular, renal, and mortality benefits.
Pulse Today

NICE confirms first-line SGLT-2 prescribing in final type 2 diabetes guidance

Most people with type 2 diabetes should be offered SGLT-2 inhibitors much earlier in their treatment, final NICE guidance has ...
Physician's Weekly

Q&A: Paradigm Shifts in Type 2 Diabetes Management

Statistics indicate that type 2 diabetes (T2D) affects approximately 14% of the global population. This is significant ...
Open Access Government

Earlier SGLT-2 inhibitors for type 2 diabetes could cut deaths, says NICE

New guidance from NICE recommends earlier use of SGLT-2 inhibitors and personalised treatment for people with type 2 diabetes ...
The BMJ

Type 2 diabetes: SGLT-2 inhibitors should be offered as first line treatment, doctors are told

Doctors should prescribe a sodium-glucose cotransporter-2 (SGLT-2) inhibitor alongside metformin to most patients with newly diagnosed type 2 diabetes, the National Institute for Health and Care ...
sciencex

Guideline on lifestyle interventions for treatment and remission of type 2 diabetes and prediabetes in adults

The American College of Lifestyle Medicine (ACLM) has published the first clinical practice guideline to put lifestyle interventions at the forefront of type 2 diabetes and prediabetes care.